One-Month Dual Antiplatelet Therapy Followed by P2Y12 Inhibitor Monotherapy After Biodegradable Polymer Drug-Eluting Stent Implantation ― The REIWA Region-Wide Registry ―
Circulation Journal · 24.05.2024 · 88 (6) · 876-884
DOI: 10.1253/circj.cj-24-0091 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Circulation Journal, erschienen am 24.05.2024. Verfasst von Masaru Ishida und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Iwate Medical University. Hauptthemen laut MEDLINE: Drug-Eluting Stents, Registries, Percutaneous Coronary Intervention, Purinergic P2Y Receptor Antagonists. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The safety and feasibility of using 1-month dual antiplatelet therapy (DAPT) followed by P2Y12inhibitor monotherapy for patients after percutaneous coronary intervention (PCI) with thin-strut biodegradable polymer drug-eluting stents (BP-DES) in daily clinical practice remain uncertain. METHODS AND RESULTS: The REIWA region-wide registry is a prospective study conducted in 1 PCI center and 9 local hospitals in northern Japan. A total of 1,202 patients who successfully underwent final PCI using BP-DES (Synergy: n=400; Ultimaster: n=401; Orsiro: n=401), were enrolled in the registry, and received 1-month DAPT followed by P2Y12inhibitor (prasugrel 3.75 mg/day or clopidogrel 75 mg/day) monotherapy. The primary endpoint was a composite of cardiovascular and bleeding events at 12 months, including cardiovascular death, myocardial infarction (MI), definite stent thrombosis (ST), ischemic or hemorrhagic stroke, and Thrombolysis in Myocardial Infarction (TIMI) major or minor bleeding. Based on the results of a previous study, we set the performance goal at 5.0%. Over the 1-year follow-up, the primary endpoint occurred in 3.08% of patients, which was lower than the predefined performance goal (Pnon-inferiority
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Internal Medicine, Iwate Medical University.
- Department of Cardiology, Iwate Prefectural Ofunato Hospital.
- Division of Medical Engineering, Department of Information Science, Iwate Medical University.
- Department of Cardiology, Hachinohe Red Cross Hospital.
- Department of Cardiology, Iwate Prefectural Chubu Hospital.
- Department of Cardiology, Iwate Prefectural Kuji Hospital.
Zitieren
APA
Ishida, M., Shimada, R., Takahashi, F., Niiyama, M., Ishisone, T., Matsumoto, Y., Taguchi, Y., Osaki, T., Nishiyama, O., Endo, H., Sakamoto, R., Tanaka, K., Koeda, Y., Kimura, T., Goto, I., Ninomiya, R., Sasaki, W., Itoh, T., Morino, Y., & REIWA Investigators (2024). One-Month Dual Antiplatelet Therapy Followed by P2Y12 Inhibitor Monotherapy After Biodegradable Polymer Drug-Eluting Stent Implantation ― The REIWA Region-Wide Registry ―. Circulation Journal, 88(6), 876-884. https://doi.org/10.1253/circj.cj-24-0091
Vancouver
Ishida M, Shimada R, Takahashi F, Niiyama M, Ishisone T, Matsumoto Y, et al. One-Month Dual Antiplatelet Therapy Followed by P2Y12 Inhibitor Monotherapy After Biodegradable Polymer Drug-Eluting Stent Implantation ― The REIWA Region-Wide Registry ―. Circulation Journal. 2024;88(6):876-884. doi:10.1253/circj.cj-24-0091
BibTeX
@article{Ishida2024,
author = {Ishida, Masaru and Shimada, Ryutaro and Takahashi, Fumiaki and Niiyama, Masanobu and Ishisone, Takenori and Matsumoto, Yuki and Taguchi, Yuya and Osaki, Takuya and Nishiyama, Osamu and Endo, Hiroshi and Sakamoto, Ryohei and Tanaka, Kentaro and Koeda, Yorihiko and Kimura, Takumi and Goto, Iwao and Ninomiya, Ryo and Sasaki, Wataru and Itoh, Tomonori and Morino, Yoshihiro and REIWA Investigators, REIWA Investigators},
title = {One-Month Dual Antiplatelet Therapy Followed by P2Y12 Inhibitor Monotherapy After Biodegradable Polymer Drug-Eluting Stent Implantation ― The REIWA Region-Wide Registry ―},
journal = {Circulation Journal},
year = {2024},
volume = {88},
number = {6},
pages = {876--884},
doi = {10.1253/circj.cj-24-0091}
}
EUVIMED